Skip to content Skip to footer
Belatacept: Benefits, Reviews, Info, Side Effects!
Rx Details
Belatacept
Nulojix, BMS-224818
Belatacept
Prescription
Immunosuppressant
Drugs
Prescription Only
improved kidney transplant survival, reduced risk of chronic kidney damage, lower incidence of acute rejection, better preservation of kidney function, reduced need for calcineurin inhibitors
Anemia, Constipation, Cough, Diarrhea, Fever, Headache, Hyperglycemia, Hyperkalemia, Hypertension, Hypokalemia, Hypophosphatemia, Leukopenia, Nausea, Neutropenia, Peripheral Edema, Post-Transplant Lymphoproliferative Disorder, Upper Respiratory Tract Infection, Urinary Tract Infection, Vomiting
Belatacept is an immunosuppressant medication primarily used to prevent organ rejection in kidney transplant patients. The dosage of belatacept can vary based on the specific treatment protocol and the patient’s condition. However, a typical dosing regimen for belatacept in adult kidney transplant patients is as follows: 1. **Initial Phase (First Month):** – 10 mg/kg on Day 1 (day of transplantation, prior to implantation) – 10 mg/kg on Day 5 – 10 mg/kg at the end of Weeks 2, 4, 8, and 12 after transplantation 2. **Maintenance Phase:** – 5 mg/kg every 4 weeks (starting at the end of Week 16 after transplantation) The dosage is calculated based on the patient’s body weight, and it is administered as an intravenous infusion. It’s important to note that the exact dosage and schedule should be determined by a healthcare professional based on individual patient needs and response to treatment. Always consult with a healthcare provider for personalized medical advice.
Kidney transplant rejection prevention
Belatacept has a generally safe safety profile.
No Interactions Reported
$1,000 – $5,000
$2500-$3,000 for a 250 mg vial.

A Synopsis of

Belatacept

Belatacept is a medication that is used to prevent organ rejection in patients who have received a kidney transplant. It works by blocking certain immune cells from attacking the transplanted kidney, helping to reduce the risk of rejection.

This medication is typically given as an infusion in a medical setting, usually every 2 to 4 weeks. It is important to follow the dosing schedule provided by your healthcare provider to ensure the best possible outcome.

Like all medications, belatacept can cause side effects. Some common side effects may include headache, nausea, and high blood pressure. It is important to report any side effects to your healthcare provider so they can be properly managed.

It is also important to discuss any other medications or supplements you are taking with your healthcare provider before starting belatacept, as there may be interactions that could affect the effectiveness of the medication.

Overall, belatacept is an important medication for patients who have received a kidney transplant and can help to improve the success of the transplant. If you have any questions or concerns about belatacept or your transplant medication regimen, be sure to speak with your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN